Skip to content
DataLookout
Menu

BONENCT04615260

Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 6 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 21 words
    • Trial completed
    • Final enrollment: 29 participants (planned 40)
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Dec 2024 to Dec 31, 2024
    • Study completion date: Apr 2025 to Apr 30, 2025
    • Site details revised
    v8
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2021 to Jul 19, 2021
    • Site details revised
    v4
  4. Notable Primary completion date: Dec 2023 to Dec 2024
    • Start date: Dec 2020 to Sep 2021
    • Study completion date: Apr 2024 to Apr 2025
    v3
  5. Notable Primary endpoints revised (2)
    • Secondary endpoints revised (2)
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Radiographic Fusion
Timeframe: 12 months
Oswestry Disability Index (ODI) 0% lowest, no disability to 100% disabled, bedridden
Timeframe: 12 months

Secondary (2)

Visual Analog Scale (VAS) 0-no pain to 10-worst possible pain
SF-36 (Short Form 36)

Arms and interventions

Single arm subject is own controlOther

Posterolateral fusion is bilateral, patients will receive the Nanobone graft on the right side of their spine and the local bone graft on their left side.

Devices: NanoBone

Sites

1 site in 1 country

  • UMass Memorial Health CareWorcester, Massachusetts, United States